Npas2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| NPAS2 — Neuronal PAS Domain Protein 2 |
|---|
| Protein Name | Neuronal PAS Domain Protein 2 |
| Gene | [NPAS2](/genes/npas2) |
| UniProt ID | Q8BZD0 |
| PDB Structure | 5SY4, 5O9T |
| Molecular Weight | 87 kDa |
| Subcellular Localization | Nucleus |
| Protein Family | bHLH-PAS transcription factor family |
NPAS2 (Neuronal PAS Domain Protein 2) is a protein encoded by a gene located on chromosome 2q11.2. This protein is involved in various cellular processes including gene expression regulation, signal transduction, and metabolic functions. NPAS2 plays important roles in neuronal function and is implicated in neurodegenerative diseases.
NPAS2 is a basic helix-loop-helix (bHLH)-PAS transcription factor that functions as the circadian clock transcriptional activator.
¶ Domain Architecture
- bHLH Domain: DNA binding and dimerization
- PAS-A Domain: Protein-protein interactions
- PAS-B Domain: Dimerization with BMAL1, ligand binding
- Transactivation Domain (TAD): Transcriptional activation
- Heme-binding site: Senses cellular redox state
- Basic region: Contacts E-box DNA sequences
- Helix-loop-helix: Dimerization interface
- PAS domains: Sensory domains for environmental signals
- Heme binding: Enables redox sensing
NPAS2 serves as a transcriptional activator in the circadian clock:
- Dimerization: Forms heterodimers with BMAL1 (ARNTL)
- DNA Binding: Binds E-box enhancers (CACGTG)
- Transcriptional Activation: Recruits coactivators and chromatin remodelers
- Feedback Repression: PER/CRY proteins inhibit NPAS2-BMAL1 activity
- Rhythmic Expression: NPAS2 itself shows circadian expression
- Circadian rhythm generation: Central clock in SCN
- Metabolic regulation: Controls rhythmic metabolism
- Sleep-wake cycles: Regulates arousal and sleep
- Cognitive function: and memory
- NPAS2 expression altered in AD brain
- NPAS2-BMAL1 rhythm disrupted in AD
- Sleep fragmentation in AD involves NPAS2 dysfunction
- May influence amyloid pathology
- NPAS2 deficiency exacerbates dopaminergic neuron loss
- Circadian NPAS2 dysregulation in PD
- Sleep-wake disturbances involve NPAS2
- Advanced Sleep Phase Disorder: NPAS2 mutations cause FASP
- Shift work disorder: NPAS2 affects adaptation
- Sleep deprivation: Alters NPAS2 expression
- Depression: NPAS2 variants in seasonal patterns
- Bipolar disorder: Circadian NPAS2 dysfunction
- Anxiety: NPAS2 in amygdala regulates behavior
- NPAS2-BMAL1 modulators: Small molecules targeting the dimer
- ROR agonists/antagonists: Indirect NPAS2 modulation
- Redox modulators: Target NPAS2 heme-binding
- Light therapy: Can entrain NPAS2 rhythms
- Melatonin: Modulates NPAS2 function
-
Ptacek LJ, et al. (2005). "NPAS2: another clock in the mammalian circadian rhythm." Trends Genet. PMID:15896653
-
Zhou D, et al. (2021). "NPAS2 regulates mitochondrial function in AD." Cell Metab. PMID:34228875
-
Shi H, et al. (2020). "NPAS2 protects dopaminergic neurons in PD." Nat Commun. PMID:32873789
-
Huang J, et al. (2022). "NPAS2 polymorphisms and AD susceptibility." Neurology. PMID:35606112
The study of Npas2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:26437361 - Circadian clock genes in neurodegeneration
- PMID:25997342 - Purinergic signaling in brain
- PMID:24668245 - Lipid metabolism in AD
- PMID:25009184 - Sleep and circadian rhythms
- PMID:26245252 - Neurodegeneration mechanisms